Polymyalgia rheumatica epidemiology and demographics

Revision as of 19:24, 1 June 2014 by Rim Halaby (talk | contribs)
Jump to navigation Jump to search

Polymyalgia Rheumatica Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polymyalgia rheumatica from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polymyalgia rheumatica epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polymyalgia rheumatica epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polymyalgia rheumatica epidemiology and demographics

CDC on Polymyalgia rheumatica epidemiology and demographics

Polymyalgia rheumatica epidemiology and demographics in the news

Blogs on Polymyalgia rheumatica epidemiology and demographics

Directions to Hospitals Treating Polymyalgia rheumatica

Risk calculators and risk factors for Polymyalgia rheumatica epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Polymyalgia rheumatica affects mostly sybjects who are more than 50 years of age. The prevalence of PMR is highest among subjects from Scandanavian countries and those from northern European origin.

Epidemiology and Demographics

  • PMR affects approximately 711,000 subjects in the United States.
  • There is a geographical association with the prevalence of PMR; in fact, PMR occurs more among subjects from Scandanavian countries and those from northern European origin.
  • PMR affects mostly affects people who are older than 50 years of age.
  • The mean age for the occurrence of PMR is 74 years.
  • PMR is twice as common in females than in males.
  • There is an association between PMR and giant cell arteritis. While 40 to 60% of patients with giant cell arteritis have PMR, 16 to 21%of patients with PMR develop giant cell arteritis.

References

Template:WH Template:WS